New study shows RSV infection in early infancy can raise asthma risk later, especially in children with allergic family ...

Two new studies suggest that nirsevimab (Beyfortus) is 80% to 89% effective in protecting infants from poor respiratory ...

The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...

The 2025–26 respiratory syncytial virus (RSV) season is shaping up to be a pivotal moment in the fight against this significant global health threat. In just the past 2 years, three products have been ...

An infant immunization for respiratory syncytial virus (RSV) is now available across Canada, but it still has to be paid for ...

Respiratory Syncytial Virus (RSV) is a common virus in babies and often starts with mild cold-like symptoms. For some infants, it can become serious quickly. This article will help you recognise early ...

VBY329 is designed for the prevention of Respiratory Syncytial Virus (RSV) infections in newborns, infants, and children, and results from ...

As the leaves begin to change and the temperature starts to cool, families are reminded of respiratory syncytial virus (RSV) ...